๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 12 Aug 2026 ยท ClinicalTrials.gov

Breast Cancer Trials in China

โ† All China trials

Every active and recruiting clinical study with an investigative site in China โ€” searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

3
Recruiting now
5
Active studies
Recruiting Phase 3
Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences ยท started 2026-03-27
๐Ÿ“ Beijing
NCT07084519 on ClinicalTrials.gov โ†—
Recruiting
Breast Cancer
Shengjing Hospital ยท started 2024-11-15
๐Ÿ“ Shenyang
NCT06690645 on ClinicalTrials.gov โ†—
Starting soon Phase 4
Breast Cancer, Chemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, Zhejiang University, School of Medicine ยท started 2023-07
๐Ÿ“ Hanzhou
NCT05841849 on ClinicalTrials.gov โ†—
Recruiting Phase 4
Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine ยท started 2022-07-10
๐Ÿ“ Hangzhou
NCT05420467 on ClinicalTrials.gov โ†—
No trials match your search.

Browse by location

Beijing ยท 65 Guangzhou ยท 30 Shanghai ยท 28 Fuzhou ยท 14 Chengdu ยท 14 Changsha ยท 13 Shenzhen ยท 12 Hangzhou ยท 11 Tianjin ยท 10 Wuhan ยท 9 Chongqing ยท 8 Changchun ยท 7

Browse by condition

Breast Cancer ยท 5 Artificial Intelligence (AI) ยท 2 Healthy ยท 2 Aneurysmal Subarachnoid Hemorrhage ยท 2 Prostate Cancer ยท 2 Nasopharyngeal Cancinoma (NPC) ยท 2 Solid Tumors ยท 2 Healthy Participants ยท 2 Ischemic Stroke ยท 2 Wet Age-related Macular Degeneratโ€ฆ ยท 2 Plaque Psoriasis ยท 2 Solid Tumor ยท 2 Colorectal Cancer ยท 2 Gastric Cancer ยท 2 Lung Cancer (NSCLC) ยท 2 Pulmonary Function ยท 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/condition/breast-cancer (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine โ€” studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.